期刊文献+

4,7-二氢普伐他汀的分离、结构解析与活性研究

Isolation, structural identification and bioactivity of 4,7-dihydropravastatin
下载PDF
导出
摘要 目的研究普伐他汀生产发酵过程中的相关物质。方法采用多种色谱技术进行分离纯化,从普伐他汀发酵液中分离得到化合物(H2PV),进行波谱学和单晶X-射线衍射分析。采用体外模型评价该化合物的抗HMG-CoA还原酶活性。结果经MS,1H-NMR,13C-NMR和单晶X-射线衍射分析,确定H2PV为4,7-二氢普伐他汀,并确定了绝对构型。该化合物无抗HMG-CoA还原酶活性。结论确证了UK标准中将4,7-二氢普伐他汀作为相关物质的科学性。 Objective To study related substances from the fermentation broth of pravastatin, Methods The compound H2PV was isolated and purified by silica gel column and pre-HPLC, and its structure was identified by spectroscopy and single-crystal X-ray diffraction. Its HMG-CoA reducase inhibitory activity was evaluated in vitro. Results The compound H2PV was identified as 4,7-dihydropravastatin by MS, ^1H-NMR, ^13C-NMR and singlecrystal X-ray diffraction. It showed no inhibitory effect on HMG-CoA reducase. Conclusion It is rational to define 4, 7-dihydropravastatin as a related substance ofpravastatin in UK pharmacopoeia.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2011年第7期526-529,共4页 Chinese Journal of Antibiotics
基金 广东省教育部产学研结合项目(2009B090300423) 广东省科技攻关项目(2010B031200002) 中央高校基本科研业务费专项资金(2009ZM0314)
关键词 分离 纯化 结构解析 4 7-二氢普伐他汀 Isolation Purification Structural identification 4.7-dihvdmnravastatin
  • 相关文献

参考文献10

  • 1Tsujita Y, Kuroda M, Tanzawa K, et al. Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-Hydroxy-3-methylglutaryl coenzyme A reductase[J]. Atherosclerosis, 1979, 32(2): 307-313.
  • 2Grundy S M. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia[J]. N Engl JMed, 1988, 319: 24-33.
  • 3Blum C B. Comparison of properties of four inhibitors of 3-hydoxy-3-methylglutary-coenzyme A reductase[J]. Am J Cardiol, 1994, 73(1): 3-11.
  • 4Park J W, Lee J K, Kwon T J, et al. Bioconversion of compactin into pravastatin by Streptomyces sp.[J]. Biotechnol Lett, 2003, 25: 1827-1831.
  • 5Peng Y, Demain A L. A new hydroxylase system in Actinomadura sp. cell converting compactin to pravastatin [J]. J Indust Microbiol Biotechnol, 1998, 20: 373-375.
  • 6董亚琳,董卫华.他汀类药物的研究进展[J].中国新药杂志,2003,12(3):175-178. 被引量:62
  • 7Bone E A, Davidson A H, Lewis C N, et al. Synthesis and biological evaluation of dihydroeptastatin, a novel inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase[J]. J Med Chern, 1992, 35: 3388-3393.
  • 8Edwards P A, Lemongello D, Fogelma A M. Improved methods for the solubilization and assay of hepatic 3-hydroxy- 3-methylglutaryl coenzyme A reductase[J]. J Lipid Res, 1979, 20: 40-46.
  • 9Bacher M, Banmann K, Knapp H, et al. Complete assignment of 1H and 13C-NMR data of pravastatin derivatives[J]. Magn Reson Chem, 2009, 47, 71-83.
  • 10Haruyarna H, Kuwano H, Kinoshita, et al. Structural elucidation of the bioaetive metabolites of ML-236B (Mevastatin) isolated from Dog Urine[J]. Chem Pharm Bull, 1986, 34(4): 1459-1467.

二级参考文献5

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部